Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on June 15, 2025
Guide Launches for Buyers of French Castles as Historic Estate Hits Market
EIN Presswire
·
June 15, 2025
New Resource and Rare Historic 17th-Century Chateau Offer Unparalleled Opportunity in the South of France UNITED KINGDOM, June 15, 2025 /EINPresswire.com/ -- The launch of a comprehensive new guide for buyers of French castles coincides with the market …
PFM Crypto Unveils Free Crypto Mining for BTC, Doge and XRP: How Beginners Can Start Crypto Mining
EIN Presswire
·
June 15, 2025
LOS ANGELES, CA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- In March 2025, the United States government passed legislation to establish a Strategic Bitcoin Reserve, marking a crucial moment for cryptocurrency adoption in the global space. This …
Great Hall _ Adaptive Reuse: A Church transforms into a Space for Care
EIN Presswire
·
June 15, 2025
Transformation of a Church into a Community Space PITTSBURGH, PA, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- The Great Hall: A Contemporary Sanctuary for Care and Community The Great Hall project reimagines a historic Pittsburgh church, …
SORIANO to Deliver Keynote Address at Climate Change Forum Zurich 2025 on the Future of E-Mobility in the EU and the USA
EIN Presswire
·
June 15, 2025
SORIANO, the pioneering innovator in electric mobility, is proud to announce its participation as a keynote speaker at the upcoming Climate Change Forum NEW YORK, NY, UNITED STATES, June 15, 2025 /EINPresswire.com/ -- SORIANO, the pioneering innovator …
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
GlobeNewswire
·
June 15, 2025
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …
Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute 1ere étude respiratoire de ph4 en comparaison directe …
GlobeNewswire
·
June 15, 2025
EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …
Seventh Presale Phase: Bitcoin Solaris Nears Public Launch with 10,000 TPS and 21M Supply Cap
GlobeNewswire
·
June 15, 2025
TALLINN, Estonia, June 15, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), a next-generation blockchain built for speed, accessibility, and long-term sustainability, has officially entered the seventh phase of its token presale, with the public launch …